Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist

スポンサーリンク

概要

• 論文の詳細を見る
• 2004-02-01

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• Shiraishi Taizo

  Department of Pathology, Faculty of Medicine, Mie University

• Yoshida Masaki

  Department of Urology, Kumamoto Hospital of Japan Labor Health and Welfare Organization, Japan

• NOGUCHI Masanori

  Department of Urology, Kurume University School of Medicine

• NODA Shinshi

  Department of Urology, Kurume University School of Medicine

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka

• Itoh Kyogo

  久留米大学 医学部免疫学

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka Jpn

• Noda Shinshi

  Department Of Urology Kurume University School Medicine

• Noda Shinshi

  Department Of Urology

• Itoh K

  Department Of Immunology Kurume University School Of Medicine

• Itoh K

  Departments Of Immunology Kurume University School Of Medicine

• Itoh Kyogo

  Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen

• Itoh Kyogo

  Department Of Immunology

• Itoh Kyogo

  Department Of Lmmunology Kurume University School Of Medicine

• UEDA SHOICHI

  Department of Urology, Kumamoto University

• Itoh Kyogo

  Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University

• Noguchi M

  Department Of Urology Kurume University School Of Medicine

• Ueda Shoichi

  Department Of Urology Kumamoto University

• Ueda Shoichi

  Department Of Electronics Faculty Of Technology Kanazawa University

• Shiraishi Taizo

  Department Of Pathology Mie University

• Nakao Masanobu

  Department Of Immunology Kurume University School Of Medicine

• Shiraishi Taizo

  Department Of Pathologic Oncology Mie University Graduate School Of Medicine

• Nishikori M

  Department Of Urology Kurume University School Of Medicine

• Noguchi Masanori

  Department Of Urology

• Yoshida Masaki

  Department Of Urology Kumamoto University

• Yoshida Masaki

  Department Of 2nd Internal Medicine Jikei University School Of Medicine

• Nakamura Masakazu

  Department Of Health Promotion And Education Osaka Medical Center For Health Science And Promotion

• Shiraishi Taizo

  Department Of Pathologic Oncology Institute Of Molecular And Experimental Medicine Mie University Gr

• Nakagawa Masayuki

  Department Of Urology Kagoshima University Hospital

• Noguchi Masanori

  Department of Health Promotion and Education, Osaka Medical Center for Health Science and Promotion

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Three Distinct Commonly Deleted Regions of Chromosome Arm 16q in Human Primary and Metastatic Prostate Cancers
• The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Pathophysiology and Pharmacotherapy of Overactive Bladder
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Measurement of Free and Bound Alcohol Metabolites and Methanol in Human Biological Samples : free and bound alcohol metabolites and methanol in acute alcohol administration
• Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Eulicin Inhibits Human Immunodeficiency Virus Infection and Replication
• Detection Limit of Laser Thomson Scattering for Low Density Discharge Plasmas
• Basic and Clinical Aspects of Non-neuronal Acetylcholine : Expression of Non-neuronal Acetylcholine in Urothelium and Its Clinical Significance
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I
• Esophageal anthracosis : Lesion mimicking malignant melanoma
• Granzyme B-positive primary gastric T-cell lymphoma : Gastric T-cell lymphoma with the possibility of extrathymic T cell origin
• Clinical guideline for male lower urinary tract symptoms
• Clinical guidelines for overactive bladder
• Immunohistochemical detection of advanced glycation end products in human bladder with specific monoclonal antibody
• Expression of two isozymes of acyl-coenzyme A : Cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma
• Glycolaldehyde-Modified Low Density Lipoprotein Leads Macrophages to Foam Cells via the Macrophage Scavenger Receptor^1
• PRLTS Gene Alterations in Human Prostate Cancer
• Microsatellite Instability and Other Molecular Abnormalities in Human Prostate Cancer
• p53 Mutations Occur in Clinical, but Not Latent, Human Prostate Carcinoma
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system : A report of five cases
• Breast cancer with choriocarcinomatous features : A case report with cytopathologic details
• Necessity of repeat biopsies in men for suspected prostate cancer
• Therapeutic Efficacy of Clenbuterol for Urinary Incontinence after Radical Prostatectomy
• Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
• Matrix-producing carcinoma of the breast : Case report with radiographical and cytopathological features
• Future research needs for the definition/diagnosis of interstitial cystitis
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan
• Subcapsular Hematoma and Hypertension Following Percutaneous Needle Biopsy of a Transplanted Kidney
• Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy
• Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy
• The Role of Cyclosporine A and Interleukin-2 in Obliterative Airway Disease in a Rat Tracheal Transplant Model
• Clinical guidelines for nocturia
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• WS3-1 Gleason grading system in Japan
• 司会のことば(3. 前立腺癌の病理 : 最新の知見)
• Primary carcinoid of the testis associated with carcinoid syndrome
• Treatment of Bilateral Staghorn Calculi by Endourology and Extracorporeal Shockwave Lithotripsy : Report of 4 Cases
• Electroporation-mediated muscarinic M_3 receptor gene transfer into rat urinary bladder
• Bilateral Tonic Pupils Associated with Neurosyphilis
• Early catheter removal 3 days after radical retropubic prostatectomy
• Clinical Study on Surgical Treatment of Vesicoureteral Reflux in Children
• Cumulative Renal Damage in Dogs by Repeated Treatment with Extracorporeal Shock Waves
• Calcium nephrolithiasis and distal tubular acidosis in type 1 glycogen storage disease
• Visual Laser Ablation of the Prostate Using a Holmium : YAG Laser
• Balloon Dilatation in Benign Prostatic Hyperplasia
• Prediction of clinically insignificant prostate cancer by detection of allelic imbalance at 6q, 8p and 13q
• CS1-3 Pharmacological Treatment(Comprehensive Study 1「Treatment Strategy for Obstinate Urinary Incontinence」)
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
• Survival of Patients with Bladder Cancer : Analysis of Prognostic Factors
• Pharmacologic Actions of Temiverine (p-INN) and its Active Metabolite, RCC-36, on Isolated Human Urinary Bladder Muscle
• Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats
• Prostaglandin E_2 release from isolated bladder strips in rats with spinal cord injury
• Effect of Cyclosporin A on Isolated Rabbit Bladder and Urethral Smooth Muscle
• The primitive rhodophyte Cyanidioschyzon merolae contains a semiamylopectin-type, but not an amylose-type, α-glucan
• Interleukin-1 deficiency in combination with macrophage depletion increases susceptibility to Pseudomonas aeruginosa bacteremia
• Transurethral Electrovaporization for Giant Prostatic Hyperplasia: Report of a Case
• Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
• Role of Heparan Sulfate Proteoglycan (Syndecan-1) on the Renal Epithelial Cells During Calcium Oxalate Monohydrate Crystal Attachment
• Exploring immune therapy for renal cancer
• Bilateral Neurovascular Bundles Sparing Prostatectomy Preserves Sexual Function in Patients with Localized Prostate Cancer
• Acute-phase kidney transplants show early peak appearance in Tc-99m DTPA renogram.

もっと見る 閉じる

スポンサーリンク